Page last updated: 2024-08-21

indazoles and osimertinib

indazoles has been researched along with osimertinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baumgardner, M; Bryan, MC; Chen, Y; Eigenbrot, C; Fan, P; Gu, XH; Hanan, EJ; Heffron, TP; La, H; Malek, S; Purkey, HE; Schaefer, G; Schmidt, S; Sideris, S; Yen, I; Yu, C	1

Other Studies

1 other study(ies) available for indazoles and osimertinib

Article	Year
4-Aminoindazolyl-dihydrofuro[3,4-d]pyrimidines as non-covalent inhibitors of mutant epidermal growth factor receptor tyrosine kinase. Bioorganic & medicinal chemistry letters, 2016, Jan-15, Volume: 26, Issue:2 Topics: Acrylamides; Aniline Compounds; Animals; Binding Sites; Crystallography, X-Ray; Dogs; ErbB Receptors; Erlotinib Hydrochloride; Furans; Hepatocytes; High-Throughput Screening Assays; Humans; Hydrogen Bonding; Indazoles; Mice; Microsomes, Liver; Point Mutation; Protein Kinase Inhibitors; Pyrimidines; Rats	2016

Article

Year

4-Aminoindazolyl-dihydrofuro[3,4-d]pyrimidines as non-covalent inhibitors of mutant epidermal growth factor receptor tyrosine kinase.

Bioorganic & medicinal chemistry letters, 2016, Jan-15, Volume: 26, Issue:2

Topics: Acrylamides; Aniline Compounds; Animals; Binding Sites; Crystallography, X-Ray; Dogs; ErbB Receptors; Erlotinib Hydrochloride; Furans; Hepatocytes; High-Throughput Screening Assays; Humans; Hydrogen Bonding; Indazoles; Mice; Microsomes, Liver; Point Mutation; Protein Kinase Inhibitors; Pyrimidines; Rats

2016